
385 Hong Kong stocks rose over 100% last year, significantly increasing the number of "red bottom stocks."
As of the market close on December 31, 2025, 385 stocks in the Hong Kong stock market saw an annual increase of over 100%, among which 14 stocks had price increases exceeding 10 times. BASETROPHY GP topped the list with a 41.64-fold increase; CANBRIDGE-B, as an unprofitable biotech company listed under Chapter 18A of the Hong Kong stock market, saw an increase of over 18 times, reflecting the market's high-risk preference for innovative drug sectors; EVEREST GOLD benefited from the continuous rise in gold prices, with an annual increase of over 12 times. Additionally, the number of "red-bottom stocks" with prices exceeding HKD 100 continues to expand, with many new "red-bottom stocks" being newly listed last year, which has also become an important reflection of the significant increase in liquidity in the Hong Kong stock market. (Securities Daily)
